Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects

Tebipenem pivoxil hydrobromide (TBP‐PI‐HBr) is a novel oral carbapenem prodrug of tebipenem (TBP), the active moiety, currently in development for treating serious bacterial infections. This study assessed the bioequivalence (BE) of the clinical trial and registration tablet formulations of TBP‐PI‐H...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Vipul K., Patel, Gina, Gasink, Leanne, Bajraktari, Floni, Lei, Yang, Jain, Akash, Srivastava, Praveen, Talley, Angela K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283737/
https://www.ncbi.nlm.nih.gov/pubmed/35411579
http://dx.doi.org/10.1111/cts.13280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283737/
https://www.ncbi.nlm.nih.gov/pubmed/35411579
http://dx.doi.org/10.1111/cts.13280

Ejemplares similares